ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2022
Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Natural history and prognostic nomogram of untreated triple negative breast cancer based on SEER database.Scientific reports · 2025Article
- Evaluation of optimal strategies for breast cancer screening in Ghana: A simulation study based on a continuous tumor growth model.PloS one · 2025Article
- Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.Cancer medicine · 2023Article
- Influence of mammographic density and compressed breast thickness on true mammographic sensitivity: a cohort study.Scientific reports · 2023Article
- Tumour Growth Models of Breast Cancer for Evaluating Early Detection-A Summary and a Simulation Study.Cancers · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn recent years, biologically motivated continuous tumor growth models have been introduced for breast cancer screening data. These provide a novel framework from which mammography screening effectiveness can be studied.
methodsWe use a newly developed natural history model, which is unique in that it includes a carcinogenesis model for tumor onset, to analyze data from a large Swedish mammography cohort consisting of 65,536 participants, followed for periods of up to 6.5 years. Using patient data on age at diagnosis, tumor size, and mode of detection, as well as screening histories, we estimate distributions of patient's age at onset, (inverse) tumor growth rates, symptomatic detection rates, and screening sensitivities. We also allow the growth rate distribution to depend on the age at onset.
resultsWe estimate that by the age of 75, 13.4% of women have experienced onset. On the basis of a model that accounts for the role of mammographic density in screening sensitivity, we estimated median tumor doubling times of 167 days for tumors with onset occurring at age 40, and 207 days for tumors with onset occurring at age 60.
conclusionsWith breast cancer natural history models and population screening data, we can estimate latent processes of tumor onset, tumor growth, and mammography screening sensitivity. We can also study the relationship between the age at onset and tumor growth rates. IMPACT: Quantifying the underlying processes of breast cancer progression is important in the era of individualized screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.